PTEN and neoplasm: Notably, in PTEN-deletion cohorts, patients with PIP4K2A wild-type or transcriptional up-regulation demonstrated significantly favorable survival outcomes compared to the PIP4K2A deleted or down-regulated group, further advocating that tumor suppressive role of PIP4K2A depends on PTEN deficiency (Fig. 6, L and M).